Literature DB >> 3819475

Pathogenesis of Campylobacter fetus infections: serum resistance associated with high-molecular-weight surface proteins.

M J Blaser, P F Smith, J A Hopkins, I Heinzer, J H Bryner, W L Wang.   

Abstract

Campylobacter fetus subspecies fetus causes both systemic and diarrheal illnesses. We studied 38 strains of C. fetus isolated from 34 patients; underlying illness was present in eight (89%) of nine patients with only systemic isolates compared with three (20%) of 15 patients with only fecal isolates (P = .002). In a standardized assay of susceptibility to normal human serum, 27 (71%) strains were resistant, six (16%) had intermediate susceptibility, and five (13%) were serum sensitive. Major protein bands migrating at 100 kDa or 125 kDa on polyacrylamide gels were present in all of the 25 serum-resistant strains tested but in only four of seven serum-sensitive isolates of C. fetus from humans and animals (P = .007). The presence of these bands was associated with type A lipopolysaccharide. A low-passaged strain, 82-40, was serum resistant and contained the 100-kDa protein; however, a spontaneous mutant of this strain lacked this band and was serum sensitive. The 100-kDa and 125-kDa proteins of three strains of C. fetus were antigenically cross reactive or identical and were exposed on the surface of the C. fetus cell. Serum resistance is inherent to most C. fetus isolates from humans and is associated with the presence of cross-reactive surface proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3819475     DOI: 10.1093/infdis/155.4.696

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

1.  Electrophoretic analysis of the surface components of autoagglutinating surface array protein-positive and surface array protein-negative Aeromonas hydrophila and Aeromonas sobria.

Authors:  R P Kokka; N A Vedros; J M Janda
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

2.  Correlation between molecular size of the surface array protein and morphology and antigenicity of the Campylobacter fetus S layer.

Authors:  S Fujimoto; A Takade; K Amako; M J Blaser
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance.

Authors:  M J Blaser; P F Smith; J E Repine; K A Joiner
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

4.  Steak tartare endocarditis.

Authors:  Michael J A Reid; Evan Michael Shannon; Sanjiv M Baxi; Peter Chin-Hong
Journal:  BMJ Case Rep       Date:  2016-02-25

5.  The Salmonella typhimurium virulence plasmid complement resistance gene rck is homologous to a family of virulence-related outer membrane protein genes, including pagC and ail.

Authors:  E J Heffernan; J Harwood; J Fierer; D Guiney
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

6.  Nested DNA inversion as a paradigm of programmed gene rearrangement.

Authors:  J Dworkin; M J Blaser
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

7.  Localization of the sapA gene on a physical map of Campylobacter fetus chromosomal DNA.

Authors:  M Fujita; K Amako
Journal:  Arch Microbiol       Date:  1994       Impact factor: 2.552

8.  Shift in S-layer protein expression responsible for antigenic variation in Campylobacter fetus.

Authors:  E Wang; M M Garcia; M S Blake; Z Pei; M J Blaser
Journal:  J Bacteriol       Date:  1993-08       Impact factor: 3.490

9.  Characterization of the Campylobacter fetus sapA promoter: evidence that the sapA promoter is deleted in spontaneous mutant strains.

Authors:  M K Tummuru; M J Blaser
Journal:  J Bacteriol       Date:  1992-09       Impact factor: 3.490

10.  Conservation and diversity of sap homologues and their organization among Campylobacter fetus isolates.

Authors:  Zheng-Chao Tu; John Hui; Martin J Blaser
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.